2024-10-09 |
2024-10-08 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
5 431
+169.3%
0,91
4 942 USD
|
5 431
+169.3%
|
0,91
|
4 942 USD
|
|
2023-09-28 |
2023-09-27 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
2 500
+4.5%
1,02
2 550 USD
|
2 500
+4.5%
|
1,02
|
2 550 USD
|
|
2023-09-27 |
2023-09-26 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
2 500
+4.7%
0,90
2 250 USD
|
2 500
+4.7%
|
0,90
|
2 250 USD
|
|
2023-04-27 |
2023-04-26 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
1 497
+27.2%
1,77
2 650 USD
|
1 497
+27.2%
|
1,77
|
2 650 USD
|
|
2023-04-26 |
2023-04-25 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
1 315
+31.3%
1,89
2 485 USD
|
1 315
+31.3%
|
1,89
|
2 485 USD
|
|
2022-07-27 |
2022-07-27 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
2 500
+1.1%
0,38
950 USD
|
2 500
+1.1%
|
0,38
|
950 USD
|
|
2022-07-26 |
2022-07-26 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
2 500
+1.1%
0,37
935 USD
|
2 500
+1.1%
|
0,37
|
935 USD
|
|
2022-07-26 |
2022-07-26 |
A
Achat
|
Hamill John P.
SVP & CFO
Dirigeant
|
3 000
+4.3%
0,37
1 100 USD
|
3 000
+4.3%
|
0,37
|
1 100 USD
|
|
2022-07-05 |
2022-06-30 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
4 500
+2.1%
0,43
1 926 USD
|
4 500
+2.1%
|
0,43
|
1 926 USD
|
|
2022-03-17 |
2022-03-16 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
2 000
+1.0%
0,98
1 960 USD
|
2 000
+1.0%
|
0,98
|
1 960 USD
|
|
2022-03-15 |
2022-03-15 |
A
Achat
|
Simonson Steven
SVP, Chief Medical Officer
Dirigeant
|
5 000
+6.4%
1,00
4 999 USD
|
5 000
+6.4%
|
1,00
|
4 999 USD
|
|
2022-03-15 |
2022-03-15 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
3 000
+1.5%
0,98
2 940 USD
|
3 000
+1.5%
|
0,98
|
2 940 USD
|
|
2022-01-10 |
2021-12-30 |
V
Vente
|
Bioengine Capital Inc.
Actionnaire important
|
1 239 088
-100.0%
1,60
1 982 541 USD
|
1 239 088
-100.0%
|
1,60
|
1 982 541 USD
|
|
2022-01-10 |
2021-12-30 |
A
Achat
|
Center Laboratories, Inc.
Actionnaire important
|
1 239 088
+inf%
1,60
1 982 541 USD
|
1 239 088
+inf%
|
1,60
|
1 982 541 USD
|
|
2021-11-22 |
2021-11-19 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
930
+2.5%
1,60
1 488 USD
|
930
+2.5%
|
1,60
|
1 488 USD
|
|
2021-11-18 |
2021-11-18 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
930
+2.6%
1,61
1 497 USD
|
930
+2.6%
|
1,61
|
1 497 USD
|
|
2021-10-25 |
2021-10-22 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
3 000
+9.0%
1,90
5 700 USD
|
3 000
+9.0%
|
1,90
|
5 700 USD
|
|
2021-10-19 |
2021-10-19 |
A
Achat
|
Huang James
Administrateur non-exécutif
|
50 000
+20.7%
1,90
95 135 USD
|
50 000
+20.7%
|
1,90
|
95 135 USD
|
|
2021-10-19 |
2021-10-19 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
3 000
+9.9%
1,91
5 730 USD
|
3 000
+9.9%
|
1,91
|
5 730 USD
|
|
2021-04-20 |
2021-04-16 |
A
Achat
|
Fraser Craig
President and CEO
Administrateur exécutif
|
1 000
+3.4%
2,09
2 092 USD
|
1 000
+3.4%
|
2,09
|
2 092 USD
|
|